Details, Fiction and trastuzumab breast cancer
When trastuzumab is combined with paclitaxel, a heightened serum focus of trastuzumab has become noticed. Serum paclitaxel concentrations may also be reduced during trastuzumab therapy.[36] The mechanism and clinical significance of these interactions are unknown.Regarding molecular networking, they confirmed that Src will be the central mediator